Intervir Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Intervir Therapeutics General Information

Description

Developer of drugs intended to treat viral diseases. The company's drugs are discovered to treat viral diseases using structure action relationships (SAR) that inhibit virus-host interactions required for egress and spread of infectious virus from the cell, enabling doctors to treat diseases caused by filoviruses (Ebola and Marburg), arenaviruses (Lassa Fever and Junín), influenza A virus and rhabdoviruses (rabies).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
+1 (610) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intervir Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Aug-2015 Completed Startup
To view Intervir Therapeutics’s complete valuation and funding history, request access »

Intervir Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Mike Saporito Chief Executive Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Intervir Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UPstart Accelerator/Incubator 000 0000 000000 0
To view Intervir Therapeutics’s complete investors history, request access »